Intech Investment Management LLC Invests 560000 in Brookfield ... - MarketBeat

6461 Stock  TWD 24.45  0.25  1.03%   
Slightly above 52% of Intech Biopharm's investor base is interested to short. The analysis of current outlook of investing in Intech Biopharm suggests that many traders are impartial regarding Intech Biopharm's prospects. Intech Biopharm's investing sentiment can be driven by a variety of factors including economic data, Intech Biopharm's earnings reports, geopolitical events, and overall market trends.
Intech Biopharm stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Intech daily returns and investor perception about the current price of Intech Biopharm as well as its diversification or hedging effects on your existing portfolios.
  
Intech Investment Management LLC Invests 560000 in Brookfield ... MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Intech Biopharm Fundamental Analysis

We analyze Intech Biopharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Intech Biopharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Intech Biopharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

Intech Biopharm is rated below average in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Peers

Trending Equities

AAL  0.12   
0%
2.0%
HD  0.00   
0%
0%
C  0.53   
11.0%
0%
AA  0.59   
12.0%
0%
CVS  0.60   
13.0%
0%
AAPL  0.67   
14.0%
0%
S  0.70   
15.0%
0%
IBM  1.00   
21.0%
0%
BBY  1.15   
25.0%
0%
T  1.21   
26.0%
0%
WFC  1.73   
37.0%
0%
TGT  1.80   
39.0%
0%
MET  2.74   
60.0%
0%
INTC  2.90   
63.0%
0%
UPS  3.31   
72.0%
0%
CVX  4.56   
100.0%
0%

Additional Tools for Intech Stock Analysis

When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.